U.S. House Democrats and Republicans “Deeply Concerned” About 340B Rebate Model

U.S. House Democrats and Republicans “Deeply Concerned” About 340B Rebate Model

Update, Thursday Oct. 22, 2020, 2:45 p.m. EDT—Kalderos provided us with the following updated comment regarding members of Congress’ concerns about its 340B Pay platform to enable drug manufacturers

Read More »

340B Hospitals Ponder Next Moves After U.S. Appeals Court Setback

A note from Publisher and CEO Ted Slafsky: I encourage you to read 340B Hudson Headwaters 340B President Jim Donnelly’s sponsored content article in today issue, on the challenges 340B stakeholders have faced over the last several months, and how

Read More »

Breaking News

BREAKING: Major Developments in 340B Hospital Lawsuit and in 340B Contract Pharmacy Dispute

U.S. Appeals Court Won’t Rehear Lawsuit Over Medicare Payment Cuts for Hospitals’ 340B-Purchased Drugs

The full U.S. Court of Appeals for the District of Columbia Circuit late this afternoon denied a motion to reconsider a three-judge panel’s

Read More »

HIV/AIDS Activists March To Protest AstraZeneca’s 340B Contract Pharmacy Cutbacks

HIV/AIDS Activists March To Protest AstraZeneca’s 340B Contract Pharmacy Cutbacks

Activists aligned with the powerful grassroots group AIDS Healthcare Foundation (AHF) marched yesterday in front of drug manufacturer AstraZeneca’s Wilmington, Del., headquarters building to protest the company’s decision effective Oct.

Read More »

Sanofi Reportedly Is Not Providing Some Promised 340B Pricing

Sanofi Reportedly Is Not Providing Some Promised 340B Pricing

Some 340B covered entities report being unable to buy Sanofi covered outpatient drugs for their own pharmacies at discounted 340B prices in recent days, despite Sanofi’s assurances that its new limits

Read More »

Breaking News

BREAKING: HIV/AIDS Clinics Sue HHS Over Drug Manufacturers’ Denials of 340B Pricing

HIV/AIDS Clinics Sue HHS Over Drug Manufacturers’ Denials of 340B Pricing

(UPDATE Saturday Oct. 10, 2020, 9:20 a.m. EDT—The U.S. Health and Human Services Department (HHS) said

Read More »

More than Half of Health Care Industry Execs Expect 340B Reporting Requirements Within Five Years

A message from 340B Report Publisher and CEO Ted Slafsky: We are pleased to have a sponsored content article today from Michael Gonzalez, President and Lead Consultant, FQHC340B, a valued 340B Report sponsor. I encourage you to read it. We will

Read More »

Breaking News

BREAKING: Connecticut Attorney General Demands Five Manufacturers Cease 340B Actions

A message from 340B Report Publisher and CEO Ted Slafsky: We are pleased to have a sponsored content piece today from Powers Law, based in Washington, D.C. We will have more information about 340B Report sponsorship packages for 2021 in

Read More »

AstraZeneca and Sanofi Block Access to 340B Contract Pharmacy Pricing, Novartis Does Not (UPDATED)

AstraZeneca and Sanofi Block Access to 340B Contract Pharmacy Pricing, Novartis Does Not (UPDATED)

(UPDATED Friday Oct. 2, 2020, 4:30 p.m. EDT)

Congressman Grills Novartis Executive About Steps to Limit 340B Discounts

A Republican U.S. congressman from rural central Pennsylvania

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live